By Steve Usdin, Washington Editor
experimental Ebola vaccines and therapies might help contain the current
outbreak is sliding into hype as public health officials exaggerate how quickly
new products could be deployed and minimize the uncertainties inherent in
extrapolating success in animal studies to humans, according to Anthony Fauci,
director of NIH's National Institute
of Allergy and Infectious Diseases.
reporters at a Sept. 5 press conference, Marie-Paule Kieny, an assistant
director-general of the World
Health Organization, said there is "a realistic hope"
that blood transfusions from Ebola survivors, as well as experimental vaccines
and therapies, will be available in time to help reverse the disaster in